Don’t ignore the fact that this insider just sold shares of Alteryx, Inc. (NYSE: AYX)

We would be surprised if Alteryx, Inc. (NYSE: AYX) Shareholders haven’t noticed that co-founder and executive chairman Dean Stoecker recently sold US $ 385,000 worth of shares at US $ 83.66 per share. On the plus side, this sale was only 6.3% of their stake, so we doubt it was very meaningful, on its own.
The Last 12 Months of Insider Trading at Alteryx
In fact, the recent sale by co-founder and executive chairman Dean Stoecker wasn’t their only sale of Alteryx shares this year. Previously, they had made an even larger sale of – US $ 4.7 million shares at a price of US $ 112 per share. We usually don’t like to see insider sales, but the lower the selling price, the more it concerns us. It is heartwarming that this sale was made at a much higher price than the current share price, which is US $ 87.90. So it might not shed much light on insider confidence at current levels.
In the past year, Alteryx insiders have not purchased any shares of the company. You can see insider trading (by companies and individuals) over the past year represented in the graph below. If you want to know exactly who sold, for how much and when, just click on the graph below!
NYSE: AYX Insider Trading Volume June 24, 2021
For those who like to find winning investments this free list of growing companies with recent insider buys, might be just the ticket.
Insider ownership
I like to look at how many shares insiders own in a company, to help inform my perspective on their alignment with insiders. I think it’s a good sign if the insiders own a significant number of shares in the company. It’s great to see that Alteryx insiders own 13% of the company, worth around $ 748 million. Most shareholders would be happy to see this type of insider ownership, as it suggests that management’s incentives are well aligned with those of other shareholders.
So what do Alteryx insider trading indicate?
Insiders haven’t bought Alteryx shares in the past three months, but there have been some sales. And there has been no purchase to comfort us in the past year. The company prides itself on having a high insider participation, but we’re a little hesitant, given the history of share sales. So these insider trading can help us build a thesis on the stock, but it’s also worth knowing the risks this company faces. Example: we have spotted 2 warning signs for Alteryx you must be aware.
If you would rather consult with another company – one with potentially superior finances – then don’t miss this free list of interesting companies, which have a HIGH return on equity and low leverage.
For the purposes of this article, insiders are the persons who report their transactions to the relevant regulatory body. We currently account for open market transactions and private assignments, but not derivative transactions.
This Simply Wall St article is general in nature. It does not constitute a recommendation to buy or sell shares and does not take into account your goals or your financial situation. Our aim is to bring you long-term, targeted analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price sensitive companies or qualitative material. Simply Wall St has no position in any of the stocks mentioned.
Do you have any feedback on this item? Are you worried about the content? Get in touch with us directly. You can also send an email to the editorial team (at) simplywallst.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.